PZ Cormay S.A. Logo

PZ Cormay S.A.

Manufactures and distributes IVD reagents and analyzers for human and veterinary medicine.

CRM | WAR

Overview

Corporate Details

ISIN(s):
PLCMRAY00029
LEI:
2594006HZJ8OSNK56U87
Country:
Poland
Address:
Warszawa Puławska 303, 02-785 Warszawa
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PZ Cormay S.A. is a manufacturer and distributor of comprehensive solutions for the in-vitro diagnostics (IVD) market. With nearly 40 years of experience, the company specializes in producing high-quality diagnostic reagents and distributing advanced laboratory analyzers. Its product portfolio covers key areas of laboratory medicine, including clinical chemistry, hematology, immunology, and coagulology. The group integrates its reagent manufacturing expertise with the advanced hematology technology of its Swiss subsidiary, Orphee. Cormay provides reliable, high-performance, and cost-effective diagnostic systems to a global network of distributors, clinics, and laboratories for both human and veterinary medicine, committed to delivering trusted test results to aid in accurate medical diagnoses.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-21 06:39
Regulatory Filings
zal01_Raport_III_kwartal_2025_GK_CORMAY_PZ_CORMAY_S.A..pdf
Polish 1.8 MB
2025-10-27 12:09
Declaration of Voting Results & Voting Rights Announcements
zal01_RB_11_2025.pdf
Polish 129.5 KB
2025-10-27 12:09
Report Publication Announcement
Lista akcjonariuszy posiadających co najmniej 5% liczby głosów na NWZ PZ CORMAY…
Polish 152 bytes
2025-10-27 12:08
AGM Information
zal01_Tresc_uchwal_NWZ_PZ_CORMAY_S.A._27.10.2025.pdf
Polish 220.2 KB
2025-10-27 12:08
Report Publication Announcement
Treść uchwał NWZ PZ CORMAY S.A., które odbyło się w dniu 27.10.2025 r. - Conten…
Polish 152 bytes
2025-10-01 09:25
Pre-Annual General Meeting Information
zal01_Ogloszenie_projekty_uchwal_NWZ_PZ_CORMAY_S.A._27.10.2025.pdf
Polish 310.6 KB
2025-10-01 09:25
Report Publication Announcement
Ogłoszenie o zwołaniu NWZ PZ CORMAY S.A. na dzień 27.10.2025 r. (wraz z projekt…
Polish 152 bytes
2025-09-26 07:51
Audit Report / Information
zal02_4._Raport_z_przegladu_PZ_CORMAY_S.A._I_polrocze_2025.pdf
Polish 383.3 KB
2025-09-26 07:51
Audit Report / Information
zal03_3._Raport_z_przegladu_GK_CORMAY_I_polrocze_2025.pdf
Polish 364.5 KB
2025-09-26 07:51
Management Reports
zal04_2._Sprawozdanie_Zarzadu_GK_CORMAY_I_polrocze_2025.pdf
Polish 739.1 KB
2025-09-26 07:51
Interim / Quarterly Report
zal01_1._Sprawozdania_finansowe_GK_CORMAY_PZ_CORMAY_S.A_I_polrocze_2025.pdf
Polish 1.8 MB
2025-09-24 15:26
Related Party Transaction
Zgoda Rady Nadzorczej PZ CORMAY S.A. na zawarcie oraz zawarcie aneksów do umów …
Polish 2.0 KB
2025-05-22 12:27
AGM Information
Powołanie osób zarządzających PZ CORMAY S.A. - Content (PL)
Polish 2.9 KB
2025-05-22 12:27
AGM Information
Powołanie osób nadzorujących PZ CORMAY S.A. - Content (PL)
Polish 7.4 KB
2025-05-22 12:26
Declaration of Voting Results & Voting Rights Announcements
zal01_RB_5_2025.pdf
Polish 122.4 KB

Automate Your Workflow. Get a real-time feed of all PZ Cormay S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PZ Cormay S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PZ Cormay S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Phathom Pharmaceuticals, Inc. Logo
Develops and commercializes treatments for acid-related gastrointestinal diseases.
United States of America
PHAT
PHIBRO ANIMAL HEALTH CORP Logo
Develops animal health products, vaccines, and nutrition for livestock and companion animals.
United States of America
PAHC
Philogen Logo
Developing targeted biopharmaceuticals for oncology using proprietary ligand-based delivery.
Italy
PHIL
Phio Pharmaceuticals Corp. Logo
Developing RNAi-based immuno-oncology therapeutics for melanoma and other skin cancers.
United States of America
PHIO
Phoenix Asia Holdings Ltd Logo
A subcontractor for substructure projects and a large-scale manufacturer of fine chemicals & APIs.
United States of America
PHOE
Photocure ASA Logo
Develops photodynamic pharmaceuticals and devices to enhance bladder cancer detection for urologists.
Norway
PHO
Pierrel Logo
Global pharma company specializing in dental anesthetics and contract manufacturing services.
Italy
PRL
Develops DNA vaccines and therapeutics for companion animals and livestock.
South Korea
222670
Pluri Inc. Logo
Develops placenta-based cell therapeutics using a proprietary 3D cell-expansion platform.
Israel
PLUR
PLUS THERAPEUTICS, INC. Logo
Developing targeted radiotherapeutics for hard-to-treat cancers like glioblastoma and solid tumors.
United States of America
PSTV

Talk to a Data Expert

Have a question? We'll get back to you promptly.